The A-LIST WMM Insights Series
NCT04466722 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2022-06-15
Summary
The main purpose of the Study is to develop an understanding over time and through multiple research projects, including surveys, interviews, online focus groups, and other primary research methodologies (A-LIST Research Projects) on what matters most to individuals concerned about brain health and those with and/or affected by Alzheimer's disease and other dementias, including caregivers.
Conditions
- Alzheimer Disease
- Dementia
- Mild Cognitive Impairment
Sponsors & Collaborators
-
UsAgainstAlzheimer's
lead OTHER
Principal Investigators
-
Theresa Frangiosa, MBA · UsAgainstAlzheimer's
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-08-15
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
NCT04994847 ·Status: ENROLLING_BY_INVITATION
-
Corticolimbic Degeneration and Treatment of Dementia
NCT00768261 ·Status: COMPLETED ·Phase: PHASE4
-
Discovering Factors in the Clinical Trial Journey of Dementia Patients
NCT05850000 ·Status: NOT_YET_RECRUITING
-
Quality Improvement PrecivityAD Clinician Survey (QUIP I)
NCT05477056 ·Status: COMPLETED
-
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
NCT03089827 ·Status: ENROLLING_BY_INVITATION
-
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
NCT07222280 ·Status: RECRUITING ·Phase: NA
-
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
NCT00495820 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Comparative Study Between Alzheimer's and Multi-infarct Dementia
NCT05781139 ·Status: RECRUITING
-
Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects
NCT05363293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
NCT04770220 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Ascending Dose Study in Healthy Volunteers and Patients With Alzheimer's Disease
NCT05804383 ·Status: COMPLETED ·Phase: PHASE1
-
Open-label Extension Study in Participants With Early Alzheimer's Disease
NCT07105709 ·Status: RECRUITING ·Phase: PHASE2
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease
NCT04137926 ·Status: UNKNOWN ·Phase: NA
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits
NCT04111211 ·Status: COMPLETED
-
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
NCT04576793 ·Status: RECRUITING ·Phase: PHASE2
-
Memantine for Agitation and Aggression in Severe Alzheimer's Disease
NCT00401167 ·Status: COMPLETED ·Phase: PHASE4
-
This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults
NCT05386914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease
NCT04804618 ·Status: RECRUITING
-
ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
NCT01772095 ·Status: COMPLETED
-
Alzheimer's Plasma Extension
NCT06416072 ·Status: ACTIVE_NOT_RECRUITING
-
Enhancing Consent for Alzheimer's Research
NCT00453544 ·Status: COMPLETED ·Phase: NA
-
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia
NCT04522739 ·Status: COMPLETED ·Phase: PHASE4